Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seizure, Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01179854
What this trial is testing

Remegal Different Doses in Patients With Refractory Partial Seizures

Who this might be right for
Drug SafetyNormal Drug ToleranceSelf Efficacy
Valexfarm 60
Not applicableWithdrawnNCT00559169
What this trial is testing

Verapamil and Catamenial Epilepsy

Who this might be right for
Catamenial Epilepsy
University Health Network, Toronto 12
Large-scale testing (Phase 3)Study completedNCT00113815
What this trial is testing

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Who this might be right for
Partial Seizure DisorderEpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 118
Early research (Phase 1)Study completedNCT00181090
What this trial is testing

Use of the Atkins Diet for Children With Intractable Epilepsy: A Comparison of Daily Carbohydrate Limits

Who this might be right for
Epilepsy
Johns Hopkins University 30
Testing effectiveness (Phase 2)Study completedNCT00236691
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 188
Testing effectiveness (Phase 2)Study completedNCT00849212
What this trial is testing

An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs)

Who this might be right for
Refractory Partial Seizures
Eisai Co., Ltd. 30
Early research (Phase 1)Study completedNCT00233012
What this trial is testing

The Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures

Who this might be right for
Seizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 16
Not applicableStudy completedNCT01834482
What this trial is testing

Modified Atkins Diet Plus KetoCal for Adult Epilepsy

Who this might be right for
EpilepsySeizureMedically Resistant Epilepsy+1 more
Johns Hopkins University 80
Large-scale testing (Phase 3)WithdrawnNCT03115489
What this trial is testing

Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus

Who this might be right for
Refractory Epilepsy
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT00004758
What this trial is testing

Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment

Who this might be right for
Spasms, InfantileEpilepsy
National Center for Research Resources (NCRR) 30
Large-scale testing (Phase 3)Study completedNCT00772603
What this trial is testing

Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures

Who this might be right for
Epilepsies, Partial
Supernus Pharmaceuticals, Inc. 366
Not applicableStudy completedNCT05756621
What this trial is testing

Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest

Who this might be right for
Status EpilepticusCardiac Arrest
University of Milano Bicocca 84
Testing effectiveness (Phase 2)Study completedNCT00048490
What this trial is testing

Transcranial Magnetic Stimulation to Treat Epilepsy

Who this might be right for
Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS) 70
Post-approval studies (Phase 4)Ended earlyNCT06081283
What this trial is testing

Antiseizure Medication in Seizure Networks at Early Acute Brain Injury

Who this might be right for
Brain Injuries, AcuteBrain Injuries, TraumaticBrain Ischemia+7 more
University of North Carolina, Chapel Hill 5
Not applicableEnrolling By InvitationNCT06952764
What this trial is testing

Epilepsy Cycles Longitudinal Monitoring to Inform Personalized Seizure-risk Estimation (ECLIPSE)

Who this might be right for
Epilepsy (Treatment Refractory)
Insel Gruppe AG, University Hospital Bern 14
Large-scale testing (Phase 3)Ended earlyNCT00448539
What this trial is testing

Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

Who this might be right for
Refractory Partial Onset Seizures
Eisai Inc. 286
Not applicableEnded earlyNCT03154307
What this trial is testing

Repeated TMS at Low Frequencies to Reduce Seizure Occurrence

Who this might be right for
EpilepsyStatus EpilepticusEpilepsia Partialis Continua+1 more
Baptist Health South Florida 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07680322
What this trial is testing

The Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy

Who this might be right for
Tuberous Sclerosis ComplexEpilepsy
Aeovian Pharmaceuticals, Inc. 42
Not applicableUnknownNCT03741192
What this trial is testing

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patient's Refractory to AEDs

Who this might be right for
Epilepsy Intractable
Brain Sentinel 58
Not applicableStudy completedNCT02426047
What this trial is testing

Medium Chain Triglycerides as an Adjunct to the Modified Atkins Diet for Women With Catamenial Epilepsy

Who this might be right for
EpilepsySeizureCatamenial Epilepsy+2 more
Johns Hopkins University 16
Next Page